Medicinal chemists who reviewed the model outputs judged them to be plausible ideas for conducting the relevant part of a structure–activity relationship campaign.

“... like, you know, not a ton, but because, you know, we have, we have a large number of them. But when we get medicinal chemists to look at it, they're like, "Yeah, no, those are very plausible thoughts about, you know, how to conduct this particular part of the SAR campaign."”